Metropolis Healthcare (Mid Cap) Share Target 2024, 2025 To 2039
|
Metropolis Healthcare Limited |
|||
|
Price: ₹2,058.05 | ||
| 52 Week Low: ₹1,450.00 52 Week High: ₹2,318.30 |
|||
| Market Capital: 10,373.68 Crore (Midcap) | |||
| Healthcare -> Diagnostics & Research | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Metropolis Healthcare Share Price Target For 2024
- 1.1.1: Metropolis Healthcare Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: Metropolis Healthcare Share Price Target For 2025
- 1.2.1: Metropolis Healthcare Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Metropolis Healthcare Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
- 3: Metropolis Healthcare Brief Company Overview
- 4: Metropolis Healthcare Financial Performance
- 4.0.1: Is Metropolis Healthcare A Good Buy For Long Term?
To predict the Metropolis Healthcare's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Metropolis Healthcare Share Price Target For 2024
The line chart displays the monthly closing prices of Metropolis Healthcare with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Metropolis Healthcare shares in 2024, see the table below.
Metropolis Healthcare Share Price Target Table For 2024
| Level | Value | Analysis |
|---|---|---|
| 2024 Target 3 | 2144.75 (+4.21%) | Price Action: 19 Dec 2024 High |
| 2024 Target 2 | 2122.45 (+3.12%) | Price Action: 05 Dec 2024 High |
| 2024 Target 1 | 2096.25 (+1.85%) | Price Action: 07 Nov 2024 Low |
| Current Price | 2058.05 | Metropolis Healthcare's share price as of 20 Dec 2024 |
| Stop Loss 1 | 2050.0 (-0.40%) | Price Action: May 2024 High |
| Stop Loss 2 | 2021.44 (-1.78%) | Price Action: 21 Nov 2024 High |
| Stop Loss 3 | 1997.05 (-2.97%) | Price Action: 18 Nov 2024 Low |
Short-Term Technical Outlook
Current Technical Position: Metropolis Healthcare is displaying bearish momentum trading below key moving averages.
Key Technical Level: The 25-day moving average at ₹2128.62 serves as the nearest technical reference point.
Historical Returns: 3-month: -6.11% | 6-month: +4.04% | 1-year: +22.64%
Metropolis Healthcare Share Price Target For 2025
The line chart displays the monthly closing prices of Metropolis Healthcare with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Metropolis Healthcare shares in 2025, see the table below.
Metropolis Healthcare Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 2705.36 (+31.45%) | Price Action: Chart |
| 2025 Target 2 | 2654.92 (+29.00%) | Price Action: Chart |
| 2025 Target 1 | 2628.63 (+27.72%) | Fibonacci Extension Level 64.90% |
| Current Price | 2058.05 | Metropolis Healthcare's share price as of 20 Dec 2024 |
| Stop Loss 1 | 1933.5 (-6.06%) | Price Action: Apr 2024 High |
| Stop Loss 2 | 1909.57 (-7.22%) | Price Action: Feb 2020 High |
| Stop Loss 3 | 1886.44 (-8.34%) | Price Action: Aug 2020 High |
Long-Term Technical Outlook
52-Week Range Analysis: Metropolis Healthcare is currently trading at 70.0% of its 52-week range (₹1450 - ₹2318.3).
Long-Term Trend Analysis: The stock shows mixed long-term signals, trading near key moving averages.
Long-Term Performance: 1-year: +22.64% | 3-year: -39.44% | 5-year: +44.79%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Metropolis Healthcare Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹2,058.05 | ||
| 2024 | ₹2,312.74 | +12.38% | ₹2,347.43 |
| 2025 | ₹2,889.32 | +24.93% | ₹2,932.66 |
| 2026 | ₹3,414.20 | +18.17% | ₹3,465.41 |
| 2027 | ₹4,030.70 | +18.06% | ₹4,091.16 |
| 2028 | ₹4,592.32 | +13.93% | ₹4,661.20 |
| 2029 | ₹5,179.96 | +12.80% | ₹5,257.66 |
| 2030 | ₹5,759.65 | +11.19% | ₹5,846.04 |
| 2031 | ₹6,243.77 | +8.41% | ₹6,348.73 |
| 2032 | ₹6,896.23 | +10.45% | ₹6,999.67 |
| 2033 | ₹7,450.71 | +8.04% | ₹7,581.96 |
| 2034 | ₹8,047.18 | +8.01% | ₹8,167.89 |
| 2035 | ₹8,629.98 | +7.24% | ₹8,759.43 |
| 2036 | ₹9,073.34 | +5.14% | ₹9,270.00 |
| 2037 | ₹9,761.76 | +7.59% | ₹9,908.19 |
| 2038 | ₹10,309.09 | +5.61% | ₹10,463.73 |
| 2039 | ₹10,546.00 | +2.30% | ₹10,782.73 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Metropolis Healthcare Brief Company Overview
Metropolis Healthcare Limited: A Trusted Diagnostic Provider Metropolis Healthcare Limited is a leading diagnostic services provider in India. Established in 1981, the company has a strong market presence and a reputation for excellence. Key products and services...
include: Clinical laboratory testing: Oncology, neurology, gynecology, nephrology Health check-up packages: Men, women, senior citizens, youth, corporates Corporate wellness and hospital laboratory solutions Clinical research services Metropolis Healthcare is committed to providing accurate, reliable, and timely diagnostic services. With its diverse product range and commitment to excellence, the company is well-positioned to meet the growing demand for diagnostic services in India.Metropolis Healthcare Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 10,373.68 Crore | Market valuation of Metropolis Healthcare's shares. |
| Revenue (TTM) | 1,285.26 Crore | Total revenue generated by Metropolis Healthcare over the past twelve months. |
| Net Income (TTM) | +1,480,313,984.00 | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +18.02% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +11.51% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+13.40% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) |
+31.20% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio |
15.95 | Company's total debt divided by total shareholder equity. |
| Total Debt | 189.46 Crore | Sum of Metropolis Healthcare's current & long-term financial obligations. |
| Total Cash | 184.52 Crore | Total amount of liquid funds available to Metropolis Healthcare. |
| Beta | 0.34 | Beta is less than 1 indicating that the Metropolis Healthcare's price is less volatile than the market. |
Is Metropolis Healthcare A Good Buy For Long Term?
No valid response content found
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
